Incannex Healthcare Inc. (NASDAQ: IXHL) Stock Information | RedChip

Incannex Healthcare Inc. (NASDAQ: IXHL) Listen to this Section


$1.57
-0.2200 ( -12.30% ) 205.9K

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products.

Market Data


Open


$1.57

Previous close


$1.79

Volume


205.9K

Market cap


$27.17M

Day range


$1.51 - $2.00

52 week range


$0.80 - $12.68

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
6-k Quarterly Reports 4 Oct 26, 2023
6-k Quarterly Reports 5 Oct 19, 2023
6-k Quarterly Reports 11 Oct 10, 2023
6-k Quarterly Reports 292 Oct 05, 2023
6-k Quarterly Reports 3 Sep 08, 2023
6-k Quarterly Reports 14 Sep 01, 2023
6-k Quarterly Reports 2 Sep 01, 2023
6-k Quarterly Reports 3 Aug 24, 2023
6-k Quarterly Reports 3 Aug 22, 2023
6-k Quarterly Reports 3 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.